Treatment of Posterior Benign Paroxysmal Positional Vertigo With Mechanical Rotational Chair.
Launched by AALBORG UNIVERSITY HOSPITAL · Apr 26, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective two different treatments are for a condition called Benign Paroxysmal Positional Vertigo (BPPV), which causes sudden dizziness when a person changes their head position. The trial will compare the Epley maneuver, a common treatment, with a new method called the 360 maneuver, both performed in a special mechanical chair designed to help with BPPV. The goal is to find out which treatment works better for patients experiencing this type of vertigo.
To participate in the trial, you need to be at least 18 years old and have been diagnosed with unilateral posterior BPPV. This means that the issue is occurring on one side of your inner ear. You should also be able to understand Danish, as all instructions and communications will be in that language. Participants can expect to receive either treatment in the mechanical chair and will need to attend follow-up visits to monitor their progress. It's important to note that certain health conditions or recent treatments may make you ineligible for this trial, so be sure to discuss any concerns with your healthcare provider.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age above 18 years
- • Confirmed unilateral p-BPPV (canalithiasis and cupulolithiasis)
- • Understand written and spoken Danish
- Exclusion Criteria:
- • Pregnancy
- • Weight ≥ 150 kg and or Height ≥ 2m
- • Not possible to attend follow-up visits
- • Insufficient cooperation during diagnostic testing or treatment in the mechanical rotational chair
- • Have received treatment for BPPV in a mechanical rotational chair within the last 6 months
- • Sedative antihistamines are taken within the past 7 days
- • Comorbidities: Heart failure (EF\<40), known cerebral aneurysm, cerebrovascular events (\<3 months), and dissection disease
- • Spontaneous or gaze evoked nystagmus.
About Aalborg University Hospital
Aalborg University Hospital is a leading healthcare institution in Denmark, renowned for its commitment to advancing medical research and patient care. As a prominent clinical trial sponsor, the hospital actively engages in innovative studies aimed at improving health outcomes across various medical disciplines. With a focus on collaboration and interdisciplinary approaches, Aalborg University Hospital leverages its state-of-the-art facilities and expertise to conduct rigorous clinical trials, ensuring adherence to the highest ethical standards and regulatory requirements. The institution is dedicated to fostering a culture of research excellence, contributing valuable insights to the medical community and enhancing treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aalborg, North Denmark Region, Denmark
Patients applied
Trial Officials
Malene Hentze Hansen, MD
Principal Investigator
Department of Otolaryngology, Head & Neck Surgery and Audiology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported